LUV Newsroom
LUV Systems, Inc. reports independent efficacy results for its halō™ indoor air disinfection system based on large-scale aerosol chamber testing conducted at Microchem Laboratory. In a controlled 5,000-cubic-foot chamber, aerosolized MS2 bacteriophage—a standard surrogate for airborne viral pathogens—was reduced by >95% within 15 minutes and >99.5% within 30 minutes, demonstrating rapid and substantial decreases in airborne viral concentration relative to background.
LUV Systems, Inc. introduces a conceptual framework for evaluating indoor air safety in its article “A New Standard for Healthy Indoor Air,” adapted from its scientific paper on respiratory infection prevention. The piece emphasizes the limitations of traditional air quality metrics—such as air changes per hour (ACH)—in accurately representing airborne infection risk, noting that infection probability depends not only on ventilation but also on exposure time, pathogen characteristics, and occupant behavior.
LUV Systems, Inc. announces the release of COVID-19 inactivation results from testing conducted at Boston University Medical School, demonstrating the effectiveness of its halō Model 5R/M low-UVC air disinfection system. The study reported a 99.9% inactivation rate of the SARS-CoV-2 virus within seconds at relatively low UVC exposure levels (under 5 mJ/cm²), validating the system’s disinfection capability.
LUV Systems, Inc. announces a research collaboration with Boston University Medical School’s NEIDL biosafety laboratory to study the inactivation of SARS-CoV-2 using low-wavelength ultraviolet (UVC) light. The contract focuses on evaluating the effectiveness of multiple UVC wavelengths across real-world surfaces—such as upholstery, stainless steel, and granite—as well as in airborne conditions relevant to public indoor environments.